240 related articles for article (PubMed ID: 33197753)
1. Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross.
Windle ST; Lane KD; Gadalla NB; Liu A; Mu J; Caleon RL; Rahman RS; Sá JM; Wellems TE
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():208-217. PubMed ID: 33197753
[TBL] [Abstract][Full Text] [Related]
2. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
[TBL] [Abstract][Full Text] [Related]
3. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.
Shafik SH; Richards SN; Corry B; Martin RE
PLoS Biol; 2022 May; 20(5):e3001616. PubMed ID: 35507548
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
6. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B
Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
8. Sustained
Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
[TBL] [Abstract][Full Text] [Related]
9. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
[TBL] [Abstract][Full Text] [Related]
10. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
11. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
Sidhu AB; Uhlemann AC; Valderramos SG; Valderramos JC; Krishna S; Fidock DA
J Infect Dis; 2006 Aug; 194(4):528-35. PubMed ID: 16845638
[TBL] [Abstract][Full Text] [Related]
12. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.
Srimuang K; Miotto O; Lim P; Fairhurst RM; Kwiatkowski DP; Woodrow CJ; Imwong M;
Malar J; 2016 Nov; 15(1):541. PubMed ID: 27825353
[TBL] [Abstract][Full Text] [Related]
13. Molecular surveillance of anti-malarial resistance pfcrt, pfmdr1, and pfk13 polymorphisms in African Plasmodium falciparum imported parasites to Wuhan, China.
Cheng W; Song X; Tan H; Wu K; Li J
Malar J; 2021 May; 20(1):209. PubMed ID: 33933099
[TBL] [Abstract][Full Text] [Related]
14. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP
J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165
[TBL] [Abstract][Full Text] [Related]
15. Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Tadele G; Jawara A; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L
Malar J; 2023 Jun; 22(1):171. PubMed ID: 37270589
[TBL] [Abstract][Full Text] [Related]
16. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
[TBL] [Abstract][Full Text] [Related]
17. Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
Legrand E; Yrinesi J; Ekala MT; Péneau J; Volney B; Berger F; Bouchier C; Bertani S; Musset L; Meynard JB; Mercereau-Puijalon O
Antimicrob Agents Chemother; 2012 Mar; 56(3):1382-9. PubMed ID: 22232280
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.
Khan AQ; Pernaute-Lau L; Khattak AA; Luijcx S; Aydin-Schmidt B; Hussain M; Khan TA; Mufti FU; Morris U
Malar J; 2020 Jun; 19(1):206. PubMed ID: 32513171
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
Dahlström S; Aubouy A; Maïga-Ascofaré O; Faucher JF; Wakpo A; Ezinmègnon S; Massougbodji A; Houzé P; Kendjo E; Deloron P; Le Bras J; Houzé S
Antimicrob Agents Chemother; 2014; 58(1):1-10. PubMed ID: 24100489
[TBL] [Abstract][Full Text] [Related]
20. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
